Cargando…
Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
During antiretroviral therapy (ART) that suppresses HIV replication to below the limit-of-quantification, virions produced during ART can be detected at low frequencies in the plasma, termed residual viremia (RV). We hypothesized that a reservoir of HIV-infected cells actively produce and release vi...
Autores principales: | Aamer, Hadega A., McClure, Jan, Ko, Daisy, Maenza, Janine, Collier, Ann C., Coombs, Robert W., Mullins, James I., Frenkel, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473585/ https://www.ncbi.nlm.nih.gov/pubmed/32841299 http://dx.doi.org/10.1371/journal.ppat.1008791 |
Ejemplares similares
-
Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
por: Mellberg, Tomas, et al.
Publicado: (2011) -
Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART
por: Obregon-Perko, Veronica, et al.
Publicado: (2021) -
Supervised Treatment Interruptions Fail to Control HIV-1 Viremia
Publicado: (2004) -
Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
por: Maggiolo, Franco, et al.
Publicado: (2017) -
1564 Duration of Viral Suppression and objectively measured Antiretroviral Adherence as predictors of rebound Viremia in South Western Uganda
por: Musinguzi, Nicholas
Publicado: (2014)